Far Cry 3: Blood Dragon Creator Leaves Ubisoft

Dean Evans, best known as the creative director on Far Cry 3: Blood Dragon, has left Ubisoft. Evans worked at the company for almost 12 years, contributing to Splinter Cell and Assassin's Creed games as well as the Far Cry series; now, he plans on taking some time off to travel.

According to Game Informer, Evans was most recently working on an unannounced project at Ubisoft that was canceled. The company offered to transfer him to a different team in Paris, but Evans decided to leave the company instead of moving to a different country.

"I split with my wife, and then the project I was working on was canceled. All of this massive s--- going on at the same time and I started thinking, 'Is the best option for me to move to another foreign country?'" Evans explained. "I'm 40 this year, and it's so f---ing cliche, but you do think about it in the same way you do when you turn 30. These milestones, you start thinking about what you really want to be doing and whether you're making the right decision."

His plans now consist of moving back to the United Kingdom and taking some time off to travel. He isn't in a rush to move on to a new job. "I've been in the business now for over 20 years, nearly 12 of those have been at Ubisoft," he said. "I've never really taken much of a break."

There's a lot more in Game Informer's full interview with Evans here. Evans is most famous for spearheading work on Far Cry 3: Blood Dragon, the bizarre, experimental, retro-futuristic expansion to Far Cry 3. If you're unfamiliar with Blood Dragon, it's definitely worth checking out; you can watch our review of it in the embed above. Additionally, be sure to take a look at our history of Far Cry feature here.

In other Far Cry news, Far Cry 5 launches on PS4, Xbox One, and PC on March 27. Ubisoft recently detailed Far Cry 5's Season Pass, which comes with expansion packs that take place on Mars, in the Vietnam War, and in a zombie apocalypse and look like they take inspiration from Blood Dragon.